Seoul, South Korea · Founded 2018 · Privately Held (backing)
Developer of periodontal disease treatment drugs designed to offer periodontal disease treatment. MXBIO is based in Seoul, South Korea and was founded in 2018. It has raised $3.2 million.
Last price · $/share
—
Implied valuation
—
Total raised
$3.2M
Last round
—
How much has MXBIO raised?
$3.2Macross 0 recorded rounds
Free account
More of MXBIO with a free account
·Watch MXBIO: the Monday email on marks, rounds and moves